Trazodone vs Ambien for Sleep: Evidence, Guidelines & Safety Warnings

Quick Answer: Ambien (zolpidem) is FDA-approved for short-term treatment of insomnia with trouble falling asleep. It is a controlled substance with a boxed warning for complex sleep behaviors such as sleepwalking and sleep-driving. Trazodone is FDA-approved for major depressive disorder; low doses are commonly prescribed off-label for sleep. The American Academy of Sleep Medicine’s 2017 guideline gives a weak recommendation for zolpidem for sleep onset and maintenance and a weak recommendation against trazodone. Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia. Both drugs can cause next-day drowsiness and falls.

Trazodone vs Ambien at a Glance

Feature	Trazodone	Ambien (zolpidem)
FDA-approved use	Major depressive disorder	Short-term insomnia (sleep initiation)
Use for sleep	Off-label, usually at low doses	On-label
AASM 2017 guideline (chronic insomnia)	Weak recommendation against	Weak recommendation for (onset and maintenance)
Controlled substance	No	Yes (Schedule IV)
Boxed warning	Suicidal thoughts and behaviors in young people (antidepressant class)	Complex sleep behaviors (sleepwalking, sleep-driving)
Label dose	MDD: starts at 150 mg/day in divided doses	5 mg for women; 5 or 10 mg for men, max 10 mg
Notable risks	Orthostatic dizziness, priapism, QT prolongation, serotonin syndrome	Next-day impairment, dependence, memory problems, falls

Doses above are from the current U.S. Drug Facts or prescribing labels listed in Sources. Always follow the label on the package you buy, because store brands and formulations differ.

Different Drugs, Different Purposes

Zolpidem is a “Z-drug” that enhances the effect of GABA, the brain’s main calming chemical, at the GABA-A receptor. The Ambien prescribing information states it is indicated for the short-term treatment of insomnia characterized by difficulty with sleep initiation and that it decreased the time to fall asleep for up to 35 days in controlled studies. Extended-release zolpidem (Ambien CR) is also labeled for trouble staying asleep.

Trazodone is an antidepressant that blocks certain serotonin receptors and histamine receptors, which makes it sedating. Its label covers major depressive disorder in adults. Prescribers often use small doses at bedtime for insomnia, especially in people with depression or those who should avoid controlled substances. That use is off-label.

What the Sleep Guideline Says

The American Academy of Sleep Medicine published its clinical practice guideline on pharmacologic treatment of chronic insomnia in adults in 2017 (Sateia et al.). After reviewing the available trials, it suggested that clinicians use zolpidem to treat both sleep onset and sleep maintenance insomnia (a weak recommendation) and suggested that clinicians not use trazodone for sleep onset or maintenance insomnia (also weak). The panel judged trazodone’s measured benefits to be small relative to its potential harms in the trials available. All recommendations in the guideline were rated weak, reflecting low-quality evidence for medicines generally.

Separately, the AASM and other bodies recommend CBT-I as first-line therapy for chronic insomnia. It addresses the habits and thoughts that keep insomnia going and has lasting benefits after treatment ends.

Dosing

The Ambien label sets a recommended starting dose of 5 mg for women and 5 or 10 mg for men, taken once per night immediately before bed with at least 7 to 8 hours remaining before planned waking. The total dose should not exceed 10 mg. Doses differ by sex because women clear zolpidem more slowly, and higher morning blood levels after 10 mg increase the risk of next-day impairment of driving. The label also says long-term use is not recommended and treatment should be as short as possible.

The trazodone label’s depression dose starts at 150 mg per day in divided doses and can be increased up to 400 mg per day. Doses prescribed off-label for sleep are typically much lower, chosen by the prescriber. Trazodone is usually taken shortly after a snack or meal per the label, because food affects how it is absorbed.

Ambien Safety Warnings

Complex sleep behaviors (boxed warning)

In 2019 the FDA required its strongest warning, a boxed warning, on zolpidem, zaleplon and eszopiclone after reports of serious injuries and deaths from complex sleep behaviors, including sleepwalking, sleep-driving and doing other activities while not fully awake. People who have experienced such an episode should not take these drugs again.

Next-day impairment

Zolpidem can impair driving and alertness the next morning even when a person feels awake. Do not take it unless you can stay in bed for a full night, and do not take an extra dose during the night.

Dependence and withdrawal

Zolpidem is a Schedule IV controlled substance. The label warns that the risk of abuse and dependence increases with dose and duration, and stopping suddenly after regular use can cause withdrawal symptoms and rebound insomnia. Never combine it with alcohol, opioids or other sedatives.

Trazodone Safety Warnings

Antidepressant boxed warning

Like all antidepressants, trazodone carries a boxed warning about increased risk of suicidal thoughts and behaviors in children, adolescents and young adults. Monitor for worsening mood, especially early in treatment.

Priapism

The label warns of painful, prolonged erections (priapism). This is a medical emergency; seek immediate care for an erection lasting longer than 4 hours.

Dizziness, falls and heart rhythm

Trazodone can lower blood pressure on standing (orthostatic hypotension), causing dizziness and falls, especially in older adults getting up at night. The label also warns of QT prolongation and arrhythmias, particularly in people with heart disease, and lists serotonin syndrome risk with other serotonergic drugs. It can impair judgment and motor skills.

Older Adults

Both drugs raise fall risk in older adults. The American Geriatrics Society Beers Criteria advise avoiding Z-drugs such as zolpidem in older adults because of risks of delirium, falls, fractures and car crashes with minimal improvement in sleep. Lower doses, careful monitoring and non-drug approaches are especially important after age 65.

How Clinicians Typically Decide

Short-term trouble falling asleep without depression: an FDA-approved hypnotic such as zolpidem may be considered for a short period, alongside sleep habit changes.
Insomnia with depression: a clinician may choose an antidepressant that treats both, though trazodone at sleep doses is not an adequate depression treatment on its own.
History of substance misuse, sleepwalking, or need to avoid controlled substances: zolpidem may be a poor fit.
Chronic insomnia (3+ months): CBT-I is first line, with medication as an adjunct if needed.

Never combine trazodone and zolpidem, or either with alcohol or other sedatives, unless a prescriber has specifically directed it.

Why CBT-I Comes First

The American Academy of Sleep Medicine’s 2021 guideline on behavioral and psychological treatments for chronic insomnia (Edinger et al.) strongly recommends cognitive behavioral therapy for insomnia (CBT-I). It also conditionally recommends brief behavioral therapy, stimulus control, sleep restriction therapy and relaxation therapy as standalone options, and suggests against relying on sleep hygiene education alone.

CBT-I typically includes:

Stimulus control: using the bed only for sleep and sex, and getting up if you cannot sleep.
Sleep restriction: temporarily limiting time in bed to match actual sleep time, then expanding it.
Cognitive therapy: addressing worries and beliefs about sleep that keep insomnia going.
Relaxation and education: techniques to reduce arousal at bedtime, plus a consistent schedule.

CBT-I is available from trained clinicians, in group programs and through digital programs. Unlike medicines, its benefits tend to last after treatment ends, and it can be combined with short-term medication when a clinician thinks it helps.

When to Talk to Your Doctor or Pharmacist

Seek emergency care for an erection lasting more than 4 hours, fainting or a racing irregular heartbeat on trazodone, or after any episode of sleep-driving or other activity you do not remember on zolpidem. Contact your clinician about worsening depression or suicidal thoughts (call or text 988 in the US), insomnia lasting more than a few weeks, loud snoring or gasping during sleep, or difficulty stopping a sleep medicine.

Frequently Asked Questions

Is trazodone better than Ambien for sleep?

Not by guideline standards. The AASM 2017 guideline suggests using zolpidem and suggests not using trazodone for chronic insomnia, while noting the evidence for all sleep medicines is limited. The right choice depends on your health history.

Is trazodone addictive like Ambien?

Trazodone is not a controlled substance and is not considered habit-forming. Zolpidem is Schedule IV and can cause dependence and withdrawal.

Can you take trazodone and Ambien together?

Only if a prescriber specifically directs it. Combining sedatives increases drowsiness, falls and breathing risks.

Why is Ambien dosed lower for women?

The label says women clear zolpidem more slowly, so the starting dose is 5 mg to reduce next-day impairment.

Is trazodone FDA approved for insomnia?

No. Trazodone is approved for major depressive disorder; sleep use is off-label.

Can trazodone or Ambien cause next-day grogginess?

Yes. Both can impair alertness the next morning. The Ambien label warns about next-day impairment of driving, and the trazodone label warns it can impair judgment, thinking and motor skills. Do not drive until you know how a medicine affects you.

What is the boxed warning on Ambien?

Complex sleep behaviors such as sleepwalking and sleep-driving that have caused serious injuries and deaths.

Sources

Medical disclaimer: This article is for educational purposes and does not replace medical advice. Consult a licensed healthcare provider before starting any supplement, medication, or treatment — particularly if you are pregnant, breastfeeding, taking other medications, or have a diagnosed medical condition.